H.R. 9900, known as the "BioTech Innovation and National Security Continuation Act," proposes changes to the National Security Commission on Emergency Biotechnology. It aims to allow all appointments to the Commission to be considered valid even if the initially set authority...
Simple Explanation
The bill H.R. 9900 wants to change the rules so that a special group focused on emergency biotech can keep doing their work longer, until the end of 2026, even if some of their bosses haven't been chosen exactly as planned.